NANOLANDGLOBAL LTD
Soma Medical UK Partner,
Registered in UK.
Company No. 7199476
VAT No. GB994360877
D&B D-U-N-S® Nr: 216660216
7
Bath Place
London UK EC2A 3DR
United Kingdom
International Whatsapp Number: +353879010419
NLG Site: www.nanolandglobal.com
Email:info@somamedical.net
SM Site : www.soma-medical.co.uk
Our Soma Medical UK partners are at the forefront of providing Indoor Air Quality Assurance (IAQA) solutions to hospitals, medical centers, offices, commercial establishments and homes. With our principle office Soma Medical Malaysia having over 14 years of experience performing Indoor Air Quality evaluation and successfully solving IAQ problems in South East Asia and the Middle East, we are now poised to be leaders in the UK. We have recently developed and tested our own patented Hospital & Operation Theater Indoor Air Quality Assurance Solution Protocol that has now become a standard in some countries for the prevention bacteria, yeast and mold.
Our staff includes certified industrial hygienists, professional engineers, and health and safety specialists.
According to the World Health Organization, 30% of buildings experience some form of sick building syndrome. Problems involving mold, mildew, fungi, and bacteria, stale air, poor ventilation, odors, and microbes are commonplace.
According to Occupational Safety and Health Act (OSHA), Indoor Air Quality (IAQ) is defined as “wherein it is stated that air in which there are no known contaminants at harmful concentrations”. Nowadays, IAQ is a major concern to businesses, building managers, tenants, and employees because it can impact the health, comfort, well being, and productivity of building occupants. Studies conducted by the United States Environmental Protection Agency (USEPA) and others show that indoor environments sometimes can have levels of pollutants that are actually higher than levels found outside.
The awareness of government, consumers and farmers of possible adverse side-effects of chemicals has increased over recent decades and has resulted in regulations and the wish to reduce usage of pesticides. Reduction in the number of approved and effective pesticides especially in minor crops and drawbacks to control weeds, pests and diseases in organic production triggers
Reduction of the number of approved and effective pesticides, especially in minor crops, and drawbacks to the control of weeds, pests and diseases in organic production, triggers innovation in physical control. For disease control the usage of UVC light is used for the control of Botrytis in greenhouses.
For these problems, Soma Medical has the solution: a proactive, IAQA Management Program and solution protocol.
What is it?
Contents and Scope
Benefits
We manufacture and distribute Indoor Air Purification and Air Sterilization technology.